You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 10, October 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nephrogenous Cyclic AMP Levels in Primary Hyperparathyroidism

John C. Babka, MD; Roger H. Bower, MD; Jonas Sode, MD

Arch Intern Med. 1976;136(10):1140-1144.


Abstract

The clinical utility of urinary cyclic adenosine-3', 5'-monophosphate (cAMP) determinations has been limited by the overlap between hyperparathyroid and normal patients. We evaluated the potential of the parathyroid hormone (PTH)-dependent, nephrogenous cAMP in the diagnosis of hyperparathyroidism. Twenty-three patients with primary hyperparathyroidism and 19 control subjects had two-hour urine collections and blood sampling at midpoint. Nephrogenous cAMP level was calculated as total urinary cAMP excretion minus the amount filtered.

The total urinary cAMP excretion (micromols per gram of creatinine) was higher in hyperparathyroid patients (6.8 ±.5 SE), but overlapped with values obtained in controls (2.9 ±.15). The level of nephrogenous cAMP (percent of total) was also higher in hyperparathyroid patients (72.5 ± 1.8) than controls (26.3 ± 4.1) and clearly separated the groups. Determination of nephrogenous cAMP levels may be useful in the diagnosis of hyperparathyroidism.

(Arch Intern Med 136:1140-1144, 1976)



Author Affiliations

From the Division of Endocrinology-Metabolism, Department of Internal Medicine, National Naval Medical Center, Bethesda, Md. Dr Babka is now at the Naval Regional Medical Center, Camp LeJeune, NC.


Footnotes

Received for publication July 14, 1975; accepted March 7, 1976.

Read in part before the 56th annual meeting of the Endocrine Society, Atlanta, June 14, 1974.

The opinions expressed herein are those of the authors and cannot be construed as reflecting the views of the Navy Department or of the Naval Service at large.

Reprint requests to Naval Regional Medical Center, Camp LeJeune, NC 28542 (Dr Babka).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Alternate and Simultaneous Administrations of Calcium and Phosphorus on Calcium Metabolism in Children Receiving Total Parenteral Nutrition
Kimura et al.
JPEN J Parenter Enteral Nutr 1986;10:513-516.
ABSTRACT  

cAMP and Calcemia
NEELON
ANN INTERN MED 1977;86:821-822.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.